Kala Bio focuses on developing therapies for rare and severe diseases of the eye using its proprietary mesenchymal stem cell secretome platform. Its lead product candidate, KPI-012, had previously ...

ARLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative ...

KALA BIO Inc. (NASDAQ: KALA) jumped 37.87% to $0.88 in after-hours trading on Tuesday. Check out the current price of KALA stock here. According to Benzinga Pro data, the stock closed the regular ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Arlington biotech Kala Bio has ...

Johnny Sheffield, right, played “Boy” in the Tarzan movies opposite Johnny Weissmuller. (Photo via Wikipedia/public domain) The Lone Ranger had Tonto. Abbott had Costello. And Tarzan had “Boy.” For ...

The strike would have affected 23 shows. Broadway musicians union Local 802 AFM announced Thursday that it had reached a tentative agreement with The Broadway League to avert a strike. In a press ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement from Kala Pharmaceuticals ...

Jane Goodall, the late-trailblazing primatologist and global conservation icon, has repeatedly said she was inspired by the book Tarzan of the Apes series growing up, influencing her profound career.

Shares of Kala Bio plummeted Monday after the company said a study of its treatment for Persistent Corneal Epithelial Defect, an eye defect, missed its primary endpoints and it would stop development ...

Sept 29 (Reuters) - Kala Bio (KALA.O), opens new tab will stop developing its experimental treatment for a type of eye condition after it failed to meet the main goal in a mid-stage study, sending the ...

Performances in N.Y.C. Advertisement Supported by With the cost of staging song-and-dance spectacles skyrocketing and audiences drawn to older hits, none of the musicals that opened last season have ...

Fintel reports that on September 8, 2025, Mizuho initiated coverage of KALA BIO (NasdaqCM:KALA) with a Outperform recommendation. Analyst Price Forecast Suggests 29.69% Upside As of September 3, 2025, ...